-
s Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor Therapy
- Source: Current Topics in Medicinal Chemistry, Volume 20, Issue 5, Feb 2020, p. 333 - 335
-
- 01 Feb 2020
Preview this article:




Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor Therapy, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/ctmc/20/5/s2-1.gif
There is no abstract available.
© Bentham Science Publishers